|
ATF6B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.418300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.503000E-01 |
| Normal-vs-Stage2 |
9.095900E-02 |
| Normal-vs-Stage3 |
1.776380E-02 |
| Normal-vs-Stage4 |
2.594000E-02 |
| Stage1-vs-Stage2 |
3.170000E-01 |
| Stage1-vs-Stage3 |
7.063800E-02 |
| Stage1-vs-Stage4 |
1.431190E-01 |
| Stage2-vs-Stage3 |
7.754800E-01 |
| Stage2-vs-Stage4 |
9.087600E-01 |
| Stage3-vs-Stage4 |
8.390600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.134000E-01 |
| Normal-vs-AfricanAmerican |
5.365500E-02 |
| Normal-vs-Asian |
3.714800E-01 |
| Caucasian-vs-AfricanAmerican |
2.876400E-01 |
| Caucasian-vs-Asian |
8.994800E-01 |
| AfricanAmerican-vs-Asian |
3.003400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.050570E-01 |
| Normal-vs-Female |
7.863900E-02 |
| Male-vs-Female |
9.648800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.431200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.423220E-01 |
| Normal-vs-Age(61-80Yrs) |
6.027500E-04 |
| Normal-vs-Age(81-100Yrs) |
4.850600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.567400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.675000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.588000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.795800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.492800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.000800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.897200E-03 |
| Classical-VS-Follicular |
1.20500000000412E-06 |
| Classical-VS-Other |
3.239200E-01 |
| Classical-VS-Normal |
6.312200E-01 |
| Tall-VS-Follicular |
6.333800E-01 |
| Tall-VS-Other |
6.979200E-01 |
| Tall-VS-Normal |
5.376600E-03 |
| Follicular-VS-Other |
5.850600E-01 |
| Follicular-VS-Normal |
5.048900E-04 |
| Other-VS-Normal |
2.447400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.216080E-02 |
| Normal-vs-N1 |
8.838200E-02 |
| N0-vs-N1 |
8.316400E-01 |
|
|
